What can be done to treat a sunburn in a patient with Behçet’s disease who is taking azathioprine (Imuran)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sunburn Management in Behçet's Disease Patients on Azathioprine

Treat the sunburn with standard supportive care (cool compresses, moisturizers, NSAIDs for pain), but the critical issue is preventing future sunburns through rigorous photoprotection, as azathioprine dramatically increases UVA-induced skin cancer risk in this population. 1

Immediate Sunburn Treatment

For the current sunburn, use standard symptomatic management:

  • Cool compresses and emollient moisturizers to soothe the burn 1
  • Oral NSAIDs (if not contraindicated) for pain and inflammation 1
  • Topical corticosteroids may be applied to reduce inflammation, though avoid prolonged use on large body surface areas 1
  • Adequate hydration and monitoring for signs of severe burn or infection 1

The Critical Photoprotection Issue

The more important concern is preventing future sunburns, as azathioprine combined with UVA radiation creates a uniquely dangerous carcinogenic hazard:

  • 6-thioguanine (azathioprine's active metabolite) incorporates into DNA and has maximum absorbance at 340 nm (UVA wavelength), making the skin hypersensitive to UVA radiation that comprises 95% of solar UV 1
  • UVA photons absorbed by 6-TG-substituted DNA generate reactive oxygen species causing lethal and mutagenic DNA damage 1
  • Long-term azathioprine use (>1 year) increases non-melanoma skin cancer risk 4.3-fold (adjusted OR 4.3; 95% CI 3.1-6.0) in inflammatory disease patients 1
  • This risk is independent of other immunosuppressants and specifically attributable to thiopurines 1

Mandatory Photoprotection Measures

Rigorous photoprotection education is highly important for all dermatology patients on long-term azathioprine 1:

  • Broad-spectrum sunscreen (UVA and UVB protection) with high SPF, applied liberally and frequently 1
  • Protective clothing including wide-brimmed hats, long sleeves, and UV-protective fabrics 1
  • Avoid peak sun hours (10 AM to 4 PM) whenever possible 1
  • Absolutely avoid sun beds and deliberate tanning, as these dramatically increase risk 2
  • Seek shade and minimize cumulative UV exposure 1

Monitoring for Skin Cancer

Given the elevated cancer risk:

  • Regular skin examinations should be performed, ideally by dermatologists experienced in skin cancer surveillance 1
  • Patient education about self-examination for new or changing lesions 1
  • Lower threshold for biopsy of suspicious lesions 1

Special Considerations for Behçet's Disease

While managing the sunburn and photoprotection:

  • Continue azathioprine as prescribed, since it remains essential for controlling Behçet's disease manifestations, particularly ocular involvement 1, 3
  • Do not discontinue immunosuppression without consulting the prescribing physician, as Behçet's disease can cause severe morbidity including blindness 3, 4
  • Monitor for signs of infection in the sunburned area, as azathioprine may increase susceptibility to skin infections, particularly if skin barrier is compromised 1, 5

Common Pitfall to Avoid

The major pitfall is failing to counsel patients about photoprotection when initiating azathioprine therapy. Fair-skinned individuals are at particularly high risk and must be explicitly warned about UV exposure dangers 2. This patient education should be documented in the medical record 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Inflammatory bowel disease, azathioprine and skin cancer: case report and literature review.

European journal of gastroenterology & hepatology, 2001

Guideline

Treatment of Behçet's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A controlled trial of azathioprine in Behçet's syndrome.

The New England journal of medicine, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.